85 related articles for article (PubMed ID: 14039070)
21. Interaction of valerian extracts of different polarity with adenosine receptors: identification of isovaltrate as an inverse agonist at A1 receptors.
Lacher SK; Mayer R; Sichardt K; Nieber K; Müller CE
Biochem Pharmacol; 2007 Jan; 73(2):248-58. PubMed ID: 17097622
[TBL] [Abstract][Full Text] [Related]
22. Modulation of postsynaptic potentials in rat cortical neurons by valerian extracts macerated with different alcohols: involvement of adenosine A(1)- and GABA(A)-receptors.
Sichardt K; Vissiennon Z; Koetter U; Brattström A; Nieber K
Phytother Res; 2007 Oct; 21(10):932-7. PubMed ID: 17582590
[TBL] [Abstract][Full Text] [Related]
23. New lignans from the roots of Valeriana prionophylla with antioxidative and vasorelaxant activities.
Piccinelli AL; Arana S; Caceres A; di Villa Bianca Rd; Sorrentino R; Rastrelli L
J Nat Prod; 2004 Jul; 67(7):1135-40. PubMed ID: 15270567
[TBL] [Abstract][Full Text] [Related]
24. Essential oil composition of Valeriana officinalis L. roots cultivated in Iran. Comparative analysis between supercritical CO2 extraction and hydrodistillation.
Safaralie A; Fatemi S; Sefidkon F
J Chromatogr A; 2008 Feb; 1180(1-2):159-64. PubMed ID: 18164718
[TBL] [Abstract][Full Text] [Related]
25. Extracts of Valeriana officinalis L. s.l. show anxiolytic and antidepressant effects but neither sedative nor myorelaxant properties.
Hattesohl M; Feistel B; Sievers H; Lehnfeld R; Hegger M; Winterhoff H
Phytomedicine; 2008 Jan; 15(1-2):2-15. PubMed ID: 18160026
[TBL] [Abstract][Full Text] [Related]
26. Biological and analytical characterization of two extracts from Valeriana officinalis.
Circosta C; De Pasquale R; Samperi S; Pino A; Occhiuto F
J Ethnopharmacol; 2007 Jun; 112(2):361-7. PubMed ID: 17467210
[TBL] [Abstract][Full Text] [Related]
27. Neuropharmacological profile of hydroalcohol extract of Valeriana edulis ssp. procera roots in mice.
Oliva I; González-Trujano ME; Arrieta J; Enciso-Rodríguez R; Navarrete A
Phytother Res; 2004 Apr; 18(4):290-6. PubMed ID: 15162363
[TBL] [Abstract][Full Text] [Related]
28. (4R,4aR,6S,7S,7aS)-6-Hydroxy-7-hydroxymethyl-4-methylperhydrocyclopenta[c]pyran-1-one chloroform solvate from Valeriana laxiflora.
Khera S; Carducci MD; Gu JQ; Timmermann BN
Acta Crystallogr C; 2004 Nov; 60(Pt 11):o773-5. PubMed ID: 15528817
[TBL] [Abstract][Full Text] [Related]
29. Valeriana officinalis Linn., its polyploid forms and the structure of their rhizomes and roots.
SANYAL PK; WALLIS TE
J Pharm Pharmacol; 1957 Mar; 9(3):162-75. PubMed ID: 13406723
[No Abstract] [Full Text] [Related]
30. A developmental toxicity-screening test of valerian.
Yao M; Ritchie HE; Brown-Woodman PD
J Ethnopharmacol; 2007 Sep; 113(2):204-9. PubMed ID: 17611059
[TBL] [Abstract][Full Text] [Related]
31. NF-kappaB modulators from Valeriana officinalis.
Jacobo-Herrera NJ; Vartiainen N; Bremner P; Gibbons S; Koistinaho J; Heinrich M
Phytother Res; 2006 Oct; 20(10):917-9. PubMed ID: 16909443
[TBL] [Abstract][Full Text] [Related]
32. [Pharmacological effects of volatile oil of Valeriana amurensis on CNS].
Wu JK; Huo JH; Du XW
Zhong Yao Cai; 2007 Aug; 30(8):977-80. PubMed ID: 18074850
[TBL] [Abstract][Full Text] [Related]
33. [Study on quality specification of Rhizoma et Radix Valeriana Jatamansi].
Di HY; Shi JL; Yan XL; Zhao R; Liu Y; Xiao PG
Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2357-9. PubMed ID: 18257257
[TBL] [Abstract][Full Text] [Related]
34. Sorbifolivaltrates A-D, diene valepotriates from Valeriana sorbifolia(1).
Xu YM; McLaughlin SP; Gunatilaka AA
J Nat Prod; 2007 Dec; 70(12):2045-8. PubMed ID: 18052324
[TBL] [Abstract][Full Text] [Related]
35. Cytotoxic potential of valerian constituents and valerian tinctures.
Bos R; Hendriks H; Scheffer JJ; Woerdenbag HJ
Phytomedicine; 1998 May; 5(3):219-25. PubMed ID: 23195845
[TBL] [Abstract][Full Text] [Related]
36. Binding studies for serotoninergic, dopaminergic and noradrenergic receptors of Valeriana adscendens Trel. extracts.
Nencini C; Cavallo F; Capasso A; De Feo V; De Martino L; Bruni G; Giorgi G; Micheli L
J Ethnopharmacol; 2006 Nov; 108(2):185-7. PubMed ID: 16839726
[TBL] [Abstract][Full Text] [Related]
37. Effect of chlorophyll and aqueous extracts of Bacopa monniera and Valeriana wallichii on ischaemia and reperfusion-induced cerebral injury in mice.
Rehni AK; Pantlya HS; Shri R; Singh M
Indian J Exp Biol; 2007 Sep; 45(9):764-9. PubMed ID: 17907741
[TBL] [Abstract][Full Text] [Related]
38. Could valerian have been the first anticonvulsant?
Eadie MJ
Epilepsia; 2004 Nov; 45(11):1338-43. PubMed ID: 15509234
[TBL] [Abstract][Full Text] [Related]
39. Exposure to airborne microorganisms, dust and endotoxin during processing of valerian roots on farms.
Skórska C; Sitkowska J; Krysińska-Traczyk E; Cholewa G; Dutkiewicz J
Ann Agric Environ Med; 2005; 12(1):119-26. PubMed ID: 16028876
[TBL] [Abstract][Full Text] [Related]
40. [Callus cultures of a Valerian species. 1. Installation of a callus culture of Valeriana Wallichii DC and 1st analytical studies].
Becker H; Schrall R; Hartmann W
Arch Pharm (Weinheim); 1977 Jun; 310(6):481-4. PubMed ID: 883877
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
